POU5F1 and neoplasm: The methylation rates at the OCT1 and OCT4 promoters were lower in ESCC (8.6% and 23.0%, respectively) compared to non-tumor tissue (18.6% and 42.5%, respectively) (Figure 3 and Table 1).